IRIS
IMPELLIZZERI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.267
EU - Europa 3.813
AS - Asia 1.040
SA - Sud America 12
OC - Oceania 6
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.140
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.263
IE - Irlanda 1.412
SE - Svezia 1.026
IT - Italia 780
CN - Cina 739
PL - Polonia 219
SG - Singapore 144
IN - India 86
FI - Finlandia 85
GB - Regno Unito 62
DE - Germania 59
VN - Vietnam 52
BE - Belgio 41
AT - Austria 36
UA - Ucraina 28
FR - Francia 20
CZ - Repubblica Ceca 16
NL - Olanda 12
BR - Brasile 10
RU - Federazione Russa 8
HK - Hong Kong 6
AU - Australia 4
CA - Canada 4
MY - Malesia 4
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CL - Cile 2
HU - Ungheria 2
KR - Corea 2
NZ - Nuova Zelanda 2
PH - Filippine 2
BD - Bangladesh 1
CH - Svizzera 1
EU - Europa 1
IL - Israele 1
JP - Giappone 1
NO - Norvegia 1
PT - Portogallo 1
SC - Seychelles 1
TR - Turchia 1
TW - Taiwan 1
Totale 9.140
Salva come PNG Salva come JPEG
Città #
Dublin 1.412
Chandler 1.004
Nyköping 797
Messina 301
Beijing 291
Princeton 276
Warsaw 218
Medford 213
Ashburn 206
Jacksonville 199
Ann Arbor 175
Des Moines 161
Dearborn 154
Boardman 97
Cambridge 84
Singapore 80
New York 77
Jinan 58
Shenyang 57
Dong Ket 51
Houston 50
San Mateo 49
Wilmington 46
Pune 42
Brussels 41
Nanjing 37
Milan 36
Vienna 35
Hyderabad 33
Lancaster 29
Los Angeles 28
Zhengzhou 26
Tianjin 25
Hebei 24
Rome 24
Haikou 23
Ningbo 23
Catania 22
Hangzhou 22
Taizhou 21
Nanchang 19
Guangzhou 18
Brno 16
Falls Church 16
Palermo 16
Seattle 15
Woodbridge 15
Fuzhou 14
Lanzhou 13
Naples 13
Pace 13
Francofonte 12
Misterbianco 10
St Louis 10
Acireale 9
Jiaxing 9
Munich 9
Norwalk 9
Berlin 8
Borghetto Santo Spirito 8
Florence 8
Floridia 8
Santa Clara 8
Tappahannock 8
Fairfield 7
Helsinki 7
Newark 7
Bremen 6
Changsha 6
Bologna 5
Brescia 5
Brooklyn 5
Carini 5
Lappeenranta 5
London 5
Washington 5
Alessandria 4
Fort Worth 4
Hefei 4
Hong Kong 4
Napoli 4
Noto 4
Reggio Calabria 4
Sannicandro Di Bari 4
Shah Alam 4
Taiyuan 4
Turin 4
Acate 3
Bronte 3
Chicago 3
Cusano Milanino 3
Dehradun 3
Genoa 3
Laurel 3
Mumbai 3
Paris 3
Strasbourg 3
Troina 3
Udine 3
Viareggio 3
Totale 6.982
Salva come PNG Salva come JPEG
Nome #
N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion 116
The association of adelmidrol with sodium hyaluronate displays beneficial properties against bladder changes following spinal cord injury in mice 116
A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models 98
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 93
Erratum to: Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. 93
The neuroprotective effects of co-ultraPEALut in a mouse model of spinal cord injury 90
Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 88
The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats 86
Dimethyl fumarate reduces inflammatory responses in experimental colitis 85
B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury 85
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism 78
Anti-inflammatory and Antioxidant Effects of Flavonoid-Rich Fraction of Bergamot Juice (BJe) in a Mouse Model of Intestinal Ischemia/Reperfusion Injury 77
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation 77
The anti-inflammatory and antioxidant potential of pistachios (Pistacia vera L.) in vitro and in vivo 77
The Neuroprotective Effects of Micronized PEA (PEA-m) Formulation on Diabetic Neuropathy in Mice 73
Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study 71
2-Pentadecyl-2-Oxazoline reduces neuroinflammatory environment in the MPTP model of Parkinson Disease 71
Adelmidrol, in combination with hyaluronic acid, displays increased anti-inflammatory and analgesic effects against monosodium iodoacetate-induced osteoarthritis in rats 70
2-Pentadecyl-2-oxazoline, the oxazoline of PEA, modulates carrageenan-induced acute inflammation 69
Aliamides update: Palmitoylethanolamide and its formulations on management of peripheral neuropathic pain 69
The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury 69
KU0063794, a Dual mTORC1 and mTORC2 Inhibitor, Reduces Neural Tissue Damage and Locomotor Impairment After Spinal Cord Injury in Mice 68
Adelmidrol: A New Promising Antioxidant and Anti-Inflammatory Therapeutic Tool in Pulmonary Fibrosis 67
N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice 66
UCP2 Regulates Mitochondrial Fission and Ventromedial Nucleus Control of Glucose Responsiveness 66
Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury 65
Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 65
N-palmitoylethanolamine administration ameliorates the clinical manifestation and progression of experimental autoimmune encephalomyelitis in rodents 64
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution 64
Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion 62
Gut-Brain Actions Underlying Comorbid  Neuropsychiatric Disturb Associated with Inflammatory Bowel Disease 61
Role of metabotropic glutamate receptors in neurological disorders 61
A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation 60
The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease. 60
The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model 59
Absence of formyl peptide receptor 1 causes endometriotic lesion regression in a mouse model of surgically-induced endometriosis 59
Gut–Brain Actions Underlying Comorbid Neuropsychiatric Disturb Associated With Inflammatory Bowel Disease 59
Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis 58
N-Palmitoylethanolamide-oxazoline Treatments Protects Against Neuroinflammatory Injury Induced by Transient Middle Cerebral Artery Occlusion in Diabetic Rats 57
2-Pentadecyl-2-Oxazoline reduces neuroinflammatory environment in the MPTP model of Parkinson Disease 56
Formyl peptide receptor 1 signalling promotes experimental colitis in mice 56
2-Pentadecyl-2-Oxazoline Reduces Neuroinflammatory Environment in the MPTP Model of Parkinson Disease 55
Deficiencies in Toll like receptors 4 impair the functional recovery in a mouse model of spinal cord trauma 55
Effect of ultra-micronized-palmitoylethanolamide and acetyl-l-carnitine on experimental model of inflammatory pain 55
Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia 54
ANTI-INFLAMMATORY EFFECT OF A NEW FORMULATION: PALMITOYLETHANOLAMIDE/BAICALEIN IN A MURINE MODEL OF MYOCARDIAL ISCHAEMIA/REPERFUSION INJURY 54
2-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation 54
Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α. 53
B Cell depletion with CD20 antibodies as new approach in the treatment of inflammatory and immunological events associated with spinal cord 53
Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 52
PBS-1086, A rel inhibitor of NF-κB, ameliorates collagen-induced arthritis in mice 52
B Cell-Targeted Therapy with Anti-CD20 Monoclonal Antibody Reduced Secondary Tissue Damage and Enhanced Behavioural Recovery Following Experimental Spinal Cord Injury in Mice 52
Formyl Peptide Receptor 1 Signaling in Acute Inflammation and Neural Differentiation Induced by Traumatic Brain Injury 52
Apocynin, a plant-derived drug, might be useful in the treatment of myocardial ischemia reperfusion injury in rat hearts 52
Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice 51
KU0063794, a dual mTORC1 and mTORC2 inhibitor, reduces neural tissue damage and locomotor impairment after spinal cord injury in mice 51
PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury. 50
Olprinone attenuates the acute inflammatory response and apoptosis after spinal cord trauma in mice. 49
Co-ultraPEALut: Role in Preclinical and Clinical Delirium Manifestations 49
Ultramicronized palmitoylethanolamide reduces inflammation an a Th1-mediated model of colitis 48
Inhibition of Poly(ADP-Ribose) Polymerase Activity Modulates Autophagy Induced by Experimental Spinal Cord Trauma 48
N-acetyl-L-cysteine reduces Leishmania amazonensis-induced inflammation in BALB/c mice 48
The protective effects of pre-and post-administration of micronized palmitoylethanolamide formulation on postoperative pain in rats 48
Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis 47
The antioxidant and anti-inflammatory properties of Anacardium occidentale l. Cashew nuts in a mouse model of colitis 47
CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation. 46
Palmitoylethanolamide Reduces Early Renal Dysfunction and Injury Caused by Experimental Ischemia and Reperfusion in Mice. 46
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury 46
Role of Toll like receptor 4 signaling pathway in the secondary damage induced by experimental spinal cord injury 46
Docosahexaenoic acid attenuates the early inflammatory response following spinal cord injury in mice: In-vivo and in-vitro studies 46
The Nutraceutical N-Palmitoylethanolamide (PEA) Reveals Widespread Molecular Effects Unmasking New Therapeutic Targets in Murine Varicocele 46
The effects of oleuropein aglycone, an olive oil compound, in a mouse model of carrageenan-induced pleurisy. 46
Autophagy and mitophagy promotion in a rat model of endometriosis 46
Aflatoxin b1 toxicity in zebrafish larva (Danio rerio): Protective role of hericium erinaceus 46
Assessment of 2-Pentadecyl-2-oxazoline Role on Lipopolysaccharide-Induced Inflammation on Early Stage Development of Zebrafish (Danio rerio) 46
Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush 45
N-Palmitoylethanolamide-Oxazoline Protects against Middle Cerebral Artery Occlusion Injury in Diabetic Rats by Regulating the SIRT1 Pathway 45
Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain 45
The absence of a functional peroxisome proliferator-activated receptor (PPAR)-α gene in miceenhances dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 44
Micronized palmitoylethanolamide reduces joint pain and glial cell activation 44
Protective effects of Colomast®, A New Formulation of Adelmidrol and Sodium Hyaluronate, in A Mouse Model of Acute Restraint Stress 44
Protective effects of apocynin, an inhibitor of NADPH oxidase activity, in splanchnic artery occlusion and reperfusion. 43
CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis. 43
Effects of a new compound containing Palmitoylethanolamide and Baicalein in myocardial ischaemia/reperfusion injury in vivo 43
Micronized palmitoylethanolamide (PEA-m): a new pharmacological strategy to prevent neurodegenerative disease associated to the old age 43
Traumatic Brain Injury Leads to Development of Parkinson's Disease in Mice 43
Biochemical Evaluation of the Antioxidant Effects of Hydroxytyrosol on Pancreatitis-Associated Gut Injury 43
Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice. 43
Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 43
Emerging drugs for acute lung injury. 42
RUOLO DELL’AUTOFAGIA NELLA NEUROINFIAMMAZIONE ASSOCIATA A LESIONI SPINALI 42
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 42
Effect of Apocynin, an inhibitor of NADPH oxidase, in the inflammatory process induced by an experimental model of spinal cord injury. 41
PPAR-α Modulates the Anti-Inflammatory Effect of Melatonin in the Secondary Events of Spinal Cord Injury 41
N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury 41
Therapeutic potential of dinitrobenzene sulfonic acid (DNBS)-induced colitis in mice by targeting IL-1beta and IL-18 41
Oral ultramicronized palmitoylethanolamide: Plasma and tissue levels and spinal anti-hyperalgesic effect 41
Topical application of adelmidrol + trans-traumatic acid enhances skin wound healing in a streptozotocin-induced diabetic mouse model 41
FeTTPs treatment reduces secondary injury associated in a mouse model of traumatic brain injury 41
The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice 41
Totale 5.738
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.597
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.597
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020862 0 7 1 113 18 150 92 56 36 240 120 29
2020/20211.354 59 29 304 69 171 35 52 174 216 141 29 75
2021/20221.531 20 96 45 63 83 37 150 69 32 79 214 643
2022/20234.157 356 371 184 300 302 371 58 254 1.762 33 124 42
2023/20241.137 109 183 73 99 86 208 29 77 21 49 23 180
2024/2025149 94 55 0 0 0 0 0 0 0 0 0 0
Totale 9.674